Literature DB >> 27903291

Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

George S Laszlo¹, Todd A Alonzo^2,3, Chelsea J Gudgeon¹, Kimberly H Harrington¹, Alex Kentsis^4,5,6, Robert B Gerbing³, Yi-Cheng Wang³, Rhonda E Ries¹, Susana C Raimondi^3,7, Betsy A Hirsch^3,8, Alan S Gamis^3,9, Soheil Meshinchi^1,3,10, Roland B Walter^11,12,13.

Abstract

Entities: Disease Gene Species

Year: 2016 PMID： 27903291 PMCID： PMC5129595 DOI： 10.1186/s13045-016-0364-0

Source DB: PubMed Journal: J Hematol Oncol ISSN： 1756-8722 Impact factor: 17.388

× No keyword cloud information.

Erratum

The original article [1] contains an omission of information in the Financial support sub-section of the Declarations section. The authors would like to acknowledge the Andrew McDonough B+ Foundation for financial support of co-author Dr Yi-Cheng Wang throughout this study, and regret this inadvertent omission from the original publication.

1 in total

1. High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Authors: George S Laszlo; Todd A Alonzo; Chelsea J Gudgeon; Kimberly H Harrington; Alex Kentsis; Robert B Gerbing; Yi-Cheng Wang; Rhonda E Ries; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Soheil Meshinchi; Roland B Walter
Journal: J Hematol Oncol Date: 2015-10-20 Impact factor: 17.388

1 in total

4 in total

1. Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs.

Authors: Ahmed A Abd-Rabou; Ahmed M Abdelaziz; Olfat G Shaker; Ghada Ayeldeen
Journal: Mol Biol Rep Date: 2021-09-01 Impact factor: 2.316

Review 2. A pharmacological exploration of targeted drug therapy in non-small cell lung cancer.

Authors: Ajay P Jayan; K R Anandu; Krishnadas Madhu; V N Saiprabha
Journal: Med Oncol Date: 2022-07-14 Impact factor: 3.738

3. The impact of Mir-9 regulation in normal and malignant hematopoiesis.

Authors: Abbas Khosravi; Shaban Alizadeh; Arsalan Jalili; Reza Shirzad; Najmaldin Saki
Journal: Oncol Rev Date: 2018-03-27

4. Construction and analysis of lncRNA-associated ceRNA network identified potential prognostic biomarker in gastric cancer.

Authors: Jingfeng Peng; Yimiao Zhu; Xin Dong; Xiaoming Mao; Yanbo Lou; Yunchuan Mu; Dan Xue; Huijiang Zhou
Journal: Transl Cancer Res Date: 2019-08 Impact factor: 1.241

4 in total